Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bay x 1005

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with bay x 1005 in 3 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(bay x 1005)
Trials
(bay x 1005)
Recent Studies (post-2010) (bay x 1005)
9,1561875525868

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)bay x 1005 (IC50)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)0.06

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dahlén, SE; Jonsson, EW1
Ahr, HJ; Beckermann, B; Bühner, K; Fruchtmann, R; Kohlsdorfer, C; Mohrs, KH; Müller-Peddinghaus, R; Perzborn, E; Theisen-Popp, P1
Fruchtmann, R; Hatzelmann, A; Mohrs, KH; Müller-Peddinghaus, R; Raddatz, S1

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and bay x 1005

ArticleYear
Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:2

    Topics: Anaphylaxis; Animals; Azepines; Guinea Pigs; Histamine; In Vitro Techniques; Indoles; Indomethacin; Leukotriene Antagonists; Leukotrienes; Lung; Male; Muscle Contraction; Ovalbumin; Platelet Activating Factor; Quinolines; Triazoles

1994
BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1

    Topics: Animals; Biological Assay; Edema; Female; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Pleurisy; Protein Binding; Quinolines; Rats

1993
Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds.
    Biochemical pharmacology, 1993, Jan-07, Volume: 45, Issue:1

    Topics: Animals; Arachidonic Acid; Binding Sites; Binding, Competitive; Cell-Free System; Humans; Hydroxyeicosatetraenoic Acids; Indoles; Kinetics; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophils; Platelet Activating Factor; Quinolines; Rats; Structure-Activity Relationship; Subcellular Fractions

1993